National Vision Holdings (EYE) logo

National Vision Holdings (EYE) stock

Eyeglasses and sunglasses , market cap $1.3B

$16.72
-1.70%

Why is EYE down?

Down 67% over five years while the S&P 500 rose 58%.

“As a percentage of net revenue, SG&A decreased 340 basis points to 48.4%, primarily driven by improved store labor efficiency, lower variable incentive compensation”

National Vision's Nov 12 release said

Sources: Price history, Nov 20, 2026; Company release, Nov 12, 2026

Tell me next time EYE moves

Free account, no card. An optional alert when EYE moves or its score changes.Pro, $1 for a first month. An optional alert when EYE moves or its score changes.Pro, 7 days free with a card. An optional alert when EYE moves or its score changes.

Or see it live, free until Tuesday morning. No account.Or see one stock in full, free. No account.
1 more reason, free with an account →See every reason on EYE →4 more reasons why EYE lags the market, from its filings, with the company's words and the timeline, for Pro members.
Quality Score
3
Below Average
In its industry
#41of 86
Checks firing
2of 14
Choppy
From 52-week high
-44.3%
under its best in a year

EYE's Quality Score fell 1 point on Fri, Nov 20, to 3. Its daily range widened again.

See EYE's 14 chart checksSee EYE's 14 chart checksSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on EYE

Key facts on EYE
Holding it backBelow its 200-day since August down 32% in a year
Latest filing8-K, Nov 12 Reported its quarterly results

EYE in the news

EYE catalysts

Coming up

After its last 4 reports it closed -4.8% on average, higher 2 of 4 times.

11 past catalysts since 2018, with sizes and sources, for Pro members.

Why EYE scores 3

Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means

  • +2Chart checks 2 of 14 firing right now, one point each
  • −2Long-term trend below a falling 200-⁠day average, down over one year
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.

No effect today: Run-up, Size, Dilution, Volatility, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on EYE and every other stock.Get in free →See the top 3 →Start Pro

Price, score, chart checks, and the industry rank are from a snapshot taken at 9:01 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How EYE ranks in Medical Devices

EYE is #41 of 86 by Quality Score.

How EYE ranks in Medical Devices
RankStockQuality Score
41National Vision Holdings (EYE) logoEYENational Vision3

More in Medical Devices

When does EYE report earnings, and what happens after?

Expected to report Wed Mar 3, before the open (in 102 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What EYE reported on Nov 12, 2026

The quarter

Sales of $510.5M, 5% more than a year ago; a profit of $0.24 a share, from $0.04.

“Net revenue increased 4.8% to $510.5 million driven by Adjusted Comparable Store Sales Growth, new store sales, partially offset by closed stores and a negative 0.8% i mpact from the timing of unearned revenue.”

The quarter that ended Oct 3, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

Where the quarter's sales came from
LineQ3
2026
Q2
2026
Q3
2025
By product
Product Salesup 4.4%$411M80%$403M81%$393M81%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 12)

1 more line, for Pro members.

The outlook

No outlook figures read from this release.

In the company's words

  • “We are updating our outlook to reflect the current consumer environment, and through continued disciplined execution, we expect to deliver full year profitability in line with our long-term algorithm.”

From its results filing (SEC filing · Nov 12)

1 more sentence, for Pro members.

The numbers

Market value
$1.3B
today
Sales
$2.1B
up 7% on the year
Free cash flow
$68.2M
last 12 months

Sales grew 3% a year over 5 years, fiscal 2020 to 2025.

Its share count fell 0.5% a year over 5 years.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on EYE: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-19.2%-11.6%+2.6%
May 13Aug 12Nov 12
ReportedGapReaction5
days
Nov 12, 2026Before open0.0%+2.6%-2.7%
Aug 12, 2026Before open-0.3%-11.6%-14.8%
May 13, 2026Before open-9.3%-19.2%-19.2%

EYE closed higher after 2 of its last 4 reports.

All 4 reports, and EYE's Quality Score going into each

EYE sales and profit by year

Sales and profit by year

Sales grew in five of the last seven years, to $2B in 2025. It turned a profit in 2025 after a loss in 2024.

EYE has 2 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on EYE, and all 14 on every stock.Get in free →See the top 3 →Start Pro

EYE RSI on Nov 20: 43.2, below its 50-day and 200-day averages

Not scored

RSI 43.2, MACD below signal, below both averages. Not scored.

The deep dive on EYE

9 more findings on EYE, each with its source, for Pro members.

EYE insider trades

One insider bought $776K across 1 filing in the last 6 months. No open-⁠market sales on record. The newest:

BuyMichael J. Nicholson$776KDirectorat $15.52 on Jun 5, filed Jun 9

EYE trades by Congress and the executive branch

One trade disclosed in the last six months. The newest:

SellDonald Trump$1K to $15KPresident (R)traded May 15, disclosed Jul 1(47 days later)

See what Congress is buying across the market

EYE's officers and directors

Officers and directors with a Form 4 in the last 12 months.

11 more officers and directors file at EYE.

See insider trades by person

Which ETFs hold EYE?

In ETFs: EYE is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About National Vision Holdings

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

13,138 employeesAlpharetta, GAnationalvision.com

What National Vision Holdings says it competes with

“The optical retail industry is highly competitive.”

From its annual report, SEC filing · Mar 4, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on EYE and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn EYE's score around: 5 things
  • 2 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayJun 9Michael J. Nicholson bought EYE$776K at $15.52, filed Jun 9

Alerts are optional.

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: EYE's Quality Score is 3 (Below Average), #41 of 86 in Medical Devices. Insiders bought $776K in the last 6 months (Form 4).

What does EYE's Quality Score say?

EYE scores 3 today, which Breakaway calls Below Average. It is #41 of 86 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Down 67% over five years while the S&P 500 rose 58%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is EYE's Quality Score?

EYE scores 3 today, which Breakaway calls Below Average (0 to 5). That is #41 of 86 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind EYE's 3.

Are insiders buying EYE?

One insider bought $776K across 1 filing in the last 6 months. No open-⁠market sales on record. The newest is Michael J. Nicholson, Director, who bought $776K on Jun 5.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.